Avid wins commercial manufacturing project from Roivant
Avid Bioservices has been selected to manufacture a commercial drug substance for Enzyvant, a subsidiary of Roivant Sciences, which is developing a therapy to treat Farber disease.
Archives for February 21, 2018
West Pharma to merge manufacturing and exit sites in network shake-up
A network reshuffle will see West Pharma consolidate manufacturing and close some facilities to “streamline” its plant network.
Scope 2018
TriNetX releases new algorithm to aid clinical trial patient identification
The global health research network TriNetX has developed a new chemotherapy lines of treatment identification algorithm to help researchers identify potential clinical trial patients.
Takeda looks to oligonucleotides in $230m CNS collaboration
Takeda Pharmaceuticals will work with Wave Life Sciences to develop nucleic acid therapies for central nervous system disorders, including Huntington’s and Lou Gehrig’s disease.
Scope 2018
Strategikon launches Clinical Maestro: 50-75% of outsourcing process costs could be eliminated, says CEO
Strategikon Pharma has released a new cloud-based solution to help plan, source, and manage clinical programs – with the goal of eliminating paper-based processes.
Biocon says FDA 483 at Malaysian plant not due to non-compliance
A US FDA pre-approval inspection of Biocon’s insulin manufacturing facility in Malaysia has resulted in a Form 483 with six observations.
Pfizer consumer health sale: Reckitt Benckiser plays down rumours
Reckitt Benckiser Group says it will be disciplined in its M&A strategy but remains silent on speculation it is buying Pfizer’s consumer healthcare business.